Axonics, Inc. (AXNX)
NASDAQ: AXNX · IEX Real-Time Price · USD
68.49
+0.30 (0.44%)
At close: Jul 26, 2024, 4:00 PM
68.70
+0.21 (0.31%)
After-hours: Jul 26, 2024, 5:36 PM EDT
Axonics Market Cap
Axonics has a market cap or net worth of $3.49 billion as of July 26, 2024. Its market cap has increased by 42.58% in one year.
Market Cap
3.49B
Enterprise Value
3.18B
1-Year Change
42.58%
Ranking
Category
Stock Price
$68.49
Market Cap Chart
Since October 31, 2018, Axonics's market cap has increased from $379.10M to $3.49B, an increase of 821.72%. That is a compound annual growth rate of 47.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 25, 2024 | 3.48B | 10.35% |
| Dec 29, 2023 | 3.15B | 1.80% |
| Dec 30, 2022 | 3.10B | 19.45% |
| Dec 31, 2021 | 2.59B | 30.46% |
| Dec 31, 2020 | 1.99B | 150.73% |
| Dec 31, 2019 | 792.60M | 88.67% |
| Dec 31, 2018 | 420.10M | 10.82% |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Merus | 3.65B |
| Biohaven Pharmaceutical Holding Company | 3.62B |
| Arrowhead Pharmaceuticals | 3.60B |
| Alvotech | 3.53B |
| Prestige Consumer Healthcare | 3.52B |
| Denali Therapeutics | 3.42B |
| Twist Bioscience | 3.37B |
| Arcellx | 3.36B |